Shares of ProPhase Labs Inc. (PRPH) Exceed 52-Week High

April 5, 2022 10:57:19

ProPhase Labs Inc. (NASDAQ:PRPH) traded at a new 52-week high today of $8.20. This new high was reached on above average trading volume as 973,000 shares traded hands, while the average 30-day volume is approximately 22,000 shares.

In the past 52 weeks, ProPhase Labs Inc. share prices are bracketed by a low of $4.41 and a high of $8.20 and is now at $7.80, 77% above that low price.

Based on a current price of $7.80, ProPhase Labs Inc. is currently 54.3% above its average consensus analyst price target of $3.56.

ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products, dietary supplements and other remedies in the United States. Its products include TK supplements such as Legendz XL, Triple Edge XL, a daily energy and stamina booster, and Super ProstaFlow to support prostate and urinary health. The company’s operating segment includes Diagnostic services and Consumer products. It generates maximum revenue from the Consumer products segment.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About IBN (InvestorBrandNetwork)

IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.

For more information on IBN, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer